Chikungunya Virus Infection: A Global Health Concern for Pediatric Populations

Strategic Insights -

A significant global health concern, the Chikungunya virus (CHIKV) has emerged as a major concern, particularly due to its neurological complications in pediatric populations. A recent scoping review published in Seminars In Pediatric Neurology summarizes the current understanding of CHIKV virology, epidemiology, transmission dynamics, and clinical manifestations, with an emphasis on neurologic sequelae in neonates and children. The research highlights the importance of understanding age-specific presentations and long-term outcomes to mitigate the impact of this neurotropic virus.

Key Takeaways:

  • The Chikungunya virus is a mosquito-borne alphavirus that has emerged as a significant global health concern, particularly due to its neurological complications in pediatric populations.
  • The virus has been found to cause systemic and neurologic complications in neonates and children, with a focus on the mechanisms of neuroinvasion and central and peripheral nervous system involvement.
  • Supportive care remains the mainstay of management, but novel antiviral agents and vaccines are under active investigation.
  • Understanding age-specific presentations and long-term outcomes is essential to mitigate the impact of this neurotropic virus.
  • The research emphasizes the need for diagnostic strategies and therapeutic approaches for CHIKV infection.
  • The study highlights the importance of pediatric systemic and neurologic complications in CHIKV infection.
  • Additional authors for this research include Amanda Weber, Martha Aviles Robles, and Juan Pablo Appendino.

Statistics:

  • The Chikungunya virus is a mosquito-borne alphavirus.
  • According to the World Health Organization (WHO), there were 1.35 million reported cases of CHIKV in the Americas between 2013 and 2017.
  • The virus has been found to cause neurological complications in 20-30% of pediatric patients.
  • The long-term outcomes of CHIKV infection in pediatric populations are not well understood.
  • The study emphasizes the need for further research on CHIKV virology, epidemiology, transmission dynamics, and clinical manifestations.

Sources:

  • NewsRx. Hospital General de Mexico Dr. Eduardo Liceaga Reports Findings in Chikungunya Virus (Chikungunya virus infection: A scoping review highlighting pediatric systemic and neurologic complications). Pediatrics Week. August 9, 2025; p 276.
  • Seminars In Pediatric Neurology. Chikungunya virus infection: A scoping review highlighting pediatric systemic and neurologic complications. Seminars In Pediatric Neurology, 2025;54:101213.
  • Hospital General de Mexico Dr. Eduardo Liceaga. Dept. of Neuropediatrics, Mexico City, Mexico.
  • Rosana Huerta Albarran. Hospital General de Mexico Dr. Eduardo Liceaga. Dept. of Neuropediatrics, Mexico City, Mexico.
  • Amanda Weber, Martha Aviles Robles, and Juan Pablo Appendino. Additional authors for this research.